Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML

NCT05986240 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

38

Enrollment

OTHER

Sponsor class

Conditions

AML/MDS
Acute Myeloid Leukemia
Myelodysplastic Syndromes

Interventions

DRUG: Danvatirsen
COMBINATION_PRODUCT: Danvatirsen + Venetoclax

Sponsor

Montefiore Medical Center

Collaborators

[object Object]
[object Object]